High concentrations of genistein regulate tau phosphorylation and Aβ40 and Aβ42 levels in the cortex and hippocampus, reducing the abnormal accumulation of harmful proteins in key brain regions and thereby preventing AD development [38]. The gene discussed is MAPT; the disease is Alzheimer disease.